Stay updated on BIVV009 Safety & Activity in Complement Disorders Clinical Trial
Sign up to get notified when there's something new on the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page.
Latest updates to the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page
- Check6 days agoChange DetectedCovance has been updated to version 2.14.1, replacing the previous version 2.14.0 from Covance Laboratories - Chantilly.SummaryDifference0.1%
- Check13 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.4%
- Check49 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check63 days agoChange DetectedThe website has removed several links to specific rare diseases and related studies, while adding a 'Show less' feature, likely streamlining the user interface.SummaryDifference4%
- Check70 days agoChange DetectedNew disease information pages have been added, including details on conditions like bullous pemphigoid and autoimmune hemolytic anemia, along with updates to the website's revision from v2.12.1 to v2.12.2.SummaryDifference4%
Stay in the know with updates to BIVV009 Safety & Activity in Complement Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page.